Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial

Published:2016-06 Issue:6 Volume:17 Page:822-835
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Vansteenkiste Johan F,Cho Byoung Chul,Vanakesa Tonu,De Pas Tommaso,Zielinski Marcin,Kim Moon Soo,Jassem Jacek,Yoshimura Masahiro,Dahabreh Jubrail,Nakayama Haruhiku,Havel Libor,Kondo Haruhiko,Mitsudomi Tetsuya,Zarogoulidis Konstantinos,Gladkov Oleg A,Udud Katalin,Tada Hirohito,Hoffman Hans,Bugge Anders,Taylor Paul,Gonzalez Emilio Esteban,Liao Mei Lin,He Jianxing,Pujol Jean-Louis,Louahed Jamila,Debois Muriel,Brichard Vincent,Debruyne Channa,Therasse Patrick,Altorki Nasser

Publisher

Elsevier BV

Subject

Oncology

Reference44 articles.

1. Reprint of: Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur J Cancer,2015

2. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Vansteenkiste;Ann Oncol,2013

3. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer;Arriagada;N Engl J Med,2004

4. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J Clin Oncol,2008

5. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial;Douillard;Lancet Oncol,2006

Cited by 398 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microdroplet-enhanced chip platform for high-throughput immunotherapy marker screening from extracellular vesicle RNAs and membrane proteins;Biosensors and Bioelectronics;2025-01

2. Proteogenomics offers a novel avenue in neoantigen identification for cancer immunotherapy;International Immunopharmacology;2024-12

3. Cationic pH-sensitive liposome-based subunit tuberculosis vaccine induces protection in mice challenged with Mycobacterium tuberculosis;European Journal of Pharmaceutics and Biopharmaceutics;2024-10

4. Increasing Power in Phase III Oncology Trials With Multivariable Regression: An Empirical Assessment of 535 Primary End Point Analyses;JCO Clinical Cancer Informatics;2024-09

5. Altered methylation of imprinted genes in neuroblastoma: implications for prognostic refinement;Journal of Translational Medicine;2024-08-31